The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
Open accessAbstract
Higher TSH values, even within normal ranges, have been associated with a greater risk of thyroid malignancy. The relationship between TSH and papillary thyroid cancer (PTC) has been analyzed in 10 178 patients submitted to fine needle aspiration of thyroid nodules with a cytology of PTC ( n =497) or benign thyroid nodular disease (BTND, n =9681). In 942 patients, submitted to surgery (521 from BTND and 421 from PTC), the histological diagnosis confirmed an elevated specificity (99.6%) and sensitivity (98.1%) of cytology. TSH levels were significantly higher in PTC than in BTND both in the cytological and histological series and also in patients with a clinical diagnosis of multinodular goiter (MNG) and single/isolate nodule (S/I). A significant age-dependent development of thyroid autonomy (TSH <0.4 μU/ml) was observed in patients with benign thyroid disease, but not in those with PTC, diagnosed both on cytology and histology. In patients with MNG, the frequency of thyroid autonomy was higher and the risk of PTC was lower compared to those with S/I. In all patients, the presence of thyroid auto-antibodies (TAb) was associated with a significant increase of TSH. However, both in TAb positive and TAb negative patients TSH levels were significantly higher in PTC than in BTND. Our data confirm a direct relationship between TSH levels and risk of PTC in patients with nodular thyroid diseases. Thyroid autonomy conceivably protects against the risk of PTC, while thyroid autoimmunity does not play a significant role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(1911) · Journal of the American Medical Association · doi:10.1001/jama.1911.04260070032017 · Cited by 3,361
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Surks, M. I., & Hollowell, J. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1499 · Cited by 750
Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patients
Mazzaferri, E. L., & Young, R. L. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90573-8 · Cited by 670
Cancer Risks in Patients with Chronic Lymphocytic Thyroiditis
Holm, L.-E., Blomgren, H., & Löwhagen, T. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503073121001 · Cited by 589
Boelaert, K., Horacek, J., Holder, R. L., Watkinson, J. C., Sheppard, M. C., & Franklyn, J. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0527 · Cited by 534
Journal of Cancer Research and Clinical Oncology
(2021) · Forum · doi:10.1007/s12312-021-00982-5 · Cited by 512
Haymart, M. R., Repplinger, D. J., Leverson, G. E., Elson, D. F., Sippel, R. S., Jaume, J. C., & Chen, H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2215 · Cited by 499
Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations
Gudmundsson, J., Sulem, P., Gudbjartsson, D. F., Jonasson, J. G., Sigurdsson, A., Bergthorsson, J. T., He, H., Blondal, T., Geller, F., Jakobsdottir, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.339 · Cited by 392
Aoki, Y., Belin, R. M., Clickner, R., Jeffries, R., Phillips, L., & Mahaffey, K. R. (2007) · Thyroid · doi:10.1089/thy.2006.0235 · Cited by 390
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
MAZZAFERRI, E. L. (1999) · Thyroid · doi:10.1089/thy.1999.9.421 · Cited by 368
The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey1
Aghini-Lombardi, F., Antonangeli, L., Martino, E., Vitti, P., Maccherini, D., Leoli, F., Rago, T., Grasso, L., Valeriano, R., Balestrieri, A., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5508 · Cited by 347
Self-citationThe Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey
Aghini-Lombardi, F. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.561 · Cited by 288
From Expert Review of Molecular Diagnostics
Mascaux, C., Peled, N., Garg, K., Kato, Y., Wynes, M. W., & Hirsch, F. R. (2010) · Cited by 280
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis
Nikiforova, M. N., & Nikiforov, Y. E. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.1.83 · Cited by 277
Suen, K. (1996) · Diagnostic Cytopathology · doi:10.1002/(sici)1097-0339(199607)15:1<84::aid-dc18>3.0.co;2-8 · Cited by 264
RET/PTC Rearrangements and BRAF Mutations in Thyroid Tumorigenesis
Ciampi, R., & Nikiforov, Y. E. (2007) · Endocrinology · doi:10.1210/en.2006-0921 · Cited by 241
Thyroid-hormone therapy and thyroid cancer: a reassessment
Biondi, B., Filetti, S., & Schlumberger, M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0020 · Cited by 224
Increasing Incidence of Thyroid Cancer in the United States, 1973–2002
Fahey, T. J. (2007) · Yearbook of Surgery · doi:10.1016/s0090-3671(08)70112-5 · Cited by 195
Endogenous Thyrotropin and Triiodothyronine Concentrations in Individuals with Thyroid Cancer
Jonklaas, J., Nsouli-Maktabi, H., & Soldin, S. J. (2008) · Thyroid · doi:10.1089/thy.2008.0061 · Cited by 124
Haymart, M. R., Glinberg, S. L., Liu, J., Sippel, R. S., Jaume, J. C., & Chen, H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03489.x · Cited by 124
Pοlyzos, S. A., Kita, M. D., Efstathiadou, Z. A., Poulakos, P., Slavakis, A., Sofianou, D., Flaris, N., Leontsini, M., Kourtis, A., & Avramidis, A. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0373-7 · Cited by 115
Ngan, E., Lang, B. H., Liu, T., Shum, C. K. Y., So, M.-T., Lau, D. K., Leon, T. Y. Y., Cherny, S. S., Tsai, S. Y., Lo, C., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn471 · Cited by 115
RECIPROCAL CHANGES OF SERUM THYROGLOBULIN AND TSH IN RESIDENTS OF A MODERATE ENDEMIC GOITRE AREA
Fenzi, G., Ceccarelli, C., Macchia, E., Monzani, F., Bartalena, L., Giani, C., CECCARELLI, P., LIPPI, F., Baschieri, L., & Pinchera, A. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00205.x · Cited by 55
Self-citationThe therapeutic management of differentiated thyroid cancer
Sipos, J. A., & Mazzaferri, E. L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2627 · Cited by 29
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Cited by
Molecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3431 · Cited by 1,426
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,288
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Thyroid and Obesity: An Intriguing Relationship
Biondi, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1245 · Cited by 330
Kitahara, C. M., Platz, E. A., Freeman, L. E. B., Hsing, A. W., Linet, M. S., Park, Y., Schairer, C., Schatzkin, A., Shikany, J. M., & Berrington de González, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1220 · Cited by 285
Metadata
- Authors
- Fiore, E., Rago, T., Provenzale, M. A., Scutari, M., Ugolini, C., Basolo, F., Di Coscio, G., Berti, P., Grasso, L., Elisei, R., Pinchera, A., & Vitti, P.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2009-12
- Volume
- 16
- Issue
- 4
- Pages
- 1251-1260
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2139752359
- Cited by
- 254
- References
- 31
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.